BlackRock Fund Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$5.88M Buy
565,440
+30,929
+6% +$321K ﹤0.01% 2856
2016
Q3
$6.63M Buy
534,511
+23,647
+5% +$293K ﹤0.01% 2705
2016
Q2
$5.49M Sell
510,864
-9,909
-2% -$106K ﹤0.01% 2743
2016
Q1
$5.75M Buy
520,773
+59,911
+13% +$661K ﹤0.01% 2670
2015
Q4
$5.63M Sell
460,862
-101,003
-18% -$1.23M ﹤0.01% 2780
2015
Q3
$9.16M Buy
561,865
+53,956
+11% +$880K ﹤0.01% 2421
2015
Q2
$10.8M Buy
507,909
+20,973
+4% +$444K ﹤0.01% 2456
2015
Q1
$8.76M Buy
486,936
+44,171
+10% +$794K ﹤0.01% 2513
2014
Q4
$7.59M Buy
+442,765
New +$7.59M ﹤0.01% 2625